Doctor of Philosophy in Pharmaceutical Economics and Policy (PhD)

School of Pharmacy

Location: Boston, Worcester
Start Term: Fall, Spring

Prepare to assume a leadership role in pharmaceutical and healthcare economics or policy with the knowledge and expertise you build in this strategic program.

Prepare for a Multitude of Career Options

This PhD program at the MCPHS Boston campus focuses on pharmaceutical and health economics as well as drug and health policy. It also provides you with training and experience in outcomes research, regulation, marketing, healthcare administration, pharmacy services research, and pharmacoepidemiology. When you graduate, you will be prepared for a career in many areas of this field, including the pharmaceutical, biotechnology, and medical device industries; healthcare; and government or academia. If accepted, you may start the program in either the fall or spring semester.

Your PhD Journey

Our deep and diverse curriculum will prepare you to pursue a number of professional paths. This program is STEM-designated, qualifying international students for an additional two years of OPT work in the United States.

First-Year Experience

  • learn about health epidemiology, health economics, outcomes research, and comparative pharmaceutical healthcare systems
  • study statistics and regression analysis
  • begin participation in a graduate seminar in pharmaceutical economics and policy

Second-Year Experience

  • explore the application of meta-analysis, pharmacoepidemiology, and patient-related outcomes
  • explore market access pricing, reimbursement, and pharmacoeconomic applications
  • complete second-year required electives

Third-Year Experience

  • complete third-year required electives
  • continue and complete your seminar requirement
  • begin the research for your PhD dissertation

Fourth-Year Experience

  • finish your dissertation research and present your findings

A Global Hub for Healthcare Innovation

Hear why the Boston campus of MCPHS is one of the best places in the world to study pharmaceutical sciences.
Longwood Medical Area

A Strategic Base for Pharmaceutical Economics and Policy

Work at the frontier of drug analysis, regulation, and safety.

MCPHS: A healthcare think tank

Learning health sciences at a university dedicated to the advancement of healthcare means that you are surrounded by peers who share your commitment to making a healthier world.

MCPHS experience

$85k average salary

Pharmaceutical scientist compensation reported by HospitalCareers.com in 2022.

Pharmaceutics students contribute to award-winning research

Terrick Andey collaborated with Pharmaceutics master’s and PhD students to develop a novel nanoparticle delivery platform.

Read Andey's story
220629_MCPHS_SwatiBetharia_12.jpg

Students Publish with Pharmaceutical Sciences Professor

Professor Swati Betharia, PhD in Pharmacology ’11, led a research team of undergraduate and graduate students to a key finding on neuroprotection against metal toxicity.

Other MCPHS Programs in Regulatory Affairs and PEP

We offer these additional opportunities for graduate study at the master’s, doctoral, and certificate levels for students interested in drug development and regulation as well as pharmaceutical economics and policy.

Master of Science in Regulatory Affairs and Health Policy

Choose full- or part-time study or whether to start in the fall, spring, or summer semester. The program takes place both on the MCPHS Boston campus and online.

Graduate Certificate in Regulatory Affairs

Start in the fall, spring, or summer semester. The program takes place both on the MCPHS Boston campus and online.

Graduate Certificate in Health Policy

Start in the fall, spring, or summer semester. The program takes place both on the MCPHS Boston campus and online.

Master of Science in Pharmaceutical Economics and Policy

Start in the fall or spring. The program takes place both on the MCPHS Boston campus and online.

Download a Program Fact Sheet

Download a program fact sheet for a snapshot of the Doctor of Philosophy in Pharmaceutical Economics and Policy.